Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor beta c chain

Blood. 1996 Dec 1;88(11):4118-23.

Abstract

BAG-1 is a Bci-2-binding protein which functions in protection from apoptotic cell death. Here we provide evidence for interleukin-2 (IL-2)-mediated upregulation of BAG-1 expression. In hematopoietic cell line BAF-B03 F7 cells, gene transfer mediated expression of the IL-2R beta c chain is sufficient to confer proliferation and cell survival responses to IL-2. In these IL-2R beta c-expressing cells, BAG-1 mRNA was dramatically induced by IL-2. The IL-2-mediated induction of BAG-1 expression required the activation of tyrosine kinase(s) and was sensitive to rapamycin as the induction of bcl-2 expression was. Analysis of the transfectants which express mutant IL-2R beta c chains or mutant Janus family protein tyrosine kinase Jak3 lacking the kinase domain showed that the IL-2-mediated BAG-1 gene expression required the serinerich region within the IL-2R beta c chain, but Jak3 activation was dispensable. The signaling pathway for BAG-1 gene expression thus highly resembles that for bcl-2 gene expression, strongly suggesting that their induction shares the same signaling pathway. In addition, deletion of the serine-rich region led to loss of IL-2-mediated protection from apoptotic cell death. Taken together, these studies demonstrate that the serine-rich region of the IL-2R beta c chain mediates the coordinated expression of bcl-2 and BAG-1 genes, thereby contributing to suppression of apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Carrier Proteins / biosynthesis*
  • Carrier Proteins / genetics
  • Cell Line
  • DNA-Binding Proteins
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation / drug effects*
  • Genistein
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Interleukin-2 / pharmacology*
  • Isoflavones / pharmacology
  • Janus Kinase 3
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism
  • Mice
  • Phosphorylation
  • Phytohemagglutinins / pharmacology
  • Polyenes / pharmacology
  • Protein Processing, Post-Translational
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / physiology
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Receptors, Interleukin-2 / chemistry*
  • Receptors, Interleukin-2 / drug effects
  • Serine*
  • Signal Transduction / drug effects*
  • Sirolimus
  • Stimulation, Chemical
  • Tacrolimus / pharmacology
  • Transcription Factors
  • Transfection

Substances

  • BCL2-associated athanogene 1 protein
  • Carrier Proteins
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Interleukin-2
  • Isoflavones
  • Phytohemagglutinins
  • Polyenes
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger
  • Receptors, Interleukin-2
  • Transcription Factors
  • Serine
  • KN 62
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Genistein
  • Protein-Tyrosine Kinases
  • JAK3 protein, human
  • Jak3 protein, mouse
  • Janus Kinase 3
  • Sirolimus
  • Tacrolimus